U-Blot® Research Grade tizetatugCat. No. WA3676Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade tizetatugCat. No. WA3676
U-Blot® Research Grade tixestobartCat. No. WA3675
U-Blot® Research Grade tixentamigCat. No. WA3674
U-Blot® Research Grade TixagevimabCat. No. WA3673
U-Blot® Research Grade Tividenofusp AlfaCat. No. WA3672
U-Blot® Research Grade TisotumabCat. No. WA3671
U-Blot® Research Grade TislelizumabCat. No. WA3670
U-Blot® Research Grade TirzepatideCat. No. WA3669
U-Blot® Research Grade TirnovetmabCat. No. WA3668
U-Blot® Research Grade TiragolumabCat. No. WA3667
U-Blot® Research Grade TinurilimabCat. No. WA3666
U-Blot® Research Grade TimolumabCat. No. WA3665